These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 19919655)

  • 1. Fibrillar IgA deposition in dermatitis herpetiformis--an underreported pattern with potential clinical significance.
    Ko CJ; Colegio OR; Moss JE; McNiff JM
    J Cutan Pathol; 2010 Apr; 37(4):475-7. PubMed ID: 19919655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis.
    Preisz K; Sárdy M; Horváth A; Kárpáti S
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):74-9. PubMed ID: 15649195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatitis herpetiformis: selective deposition of immunoglobulin A1 in granular deposits in clinically normal skin.
    Egelrud T
    Acta Derm Venereol; 1986; 66(1):11-5. PubMed ID: 2424208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatitis herpetiformis and partial IgA deficiency.
    Samolitis NJ; Hull CM; Leiferman KM; Zone JJ
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S206-9. PubMed ID: 16631941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confocal laser scanning microscopic and immunoelectron microscopic studies of the anatomical distribution of fibrillar IgA deposits in dermatitis herpetiformis.
    Kawana S; Segawa A
    Arch Dermatol; 1993 Apr; 129(4):456-9. PubMed ID: 8466215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dermatitis herpetiformis Duhring with linear deposits of IgA (linear IgA dermatosis)].
    Meurer M; Schmoeckel C; Braun-Falco O
    Hautarzt; 1984 May; 35(5):230-9. PubMed ID: 6378830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology.
    Zone JJ; Schmidt LA; Taylor TB; Hull CM; Sotiriou MC; Jaskowski TD; Hill HR; Meyer LJ
    J Immunol; 2011 Apr; 186(7):4474-80. PubMed ID: 21335491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytoclastic vasculitis as the presenting feature of dermatitis herpetiformis.
    Naylor E; Atwater A; Selim MA; Hall R; Puri PK
    Arch Dermatol; 2011 Nov; 147(11):1313-6. PubMed ID: 22106118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis.
    Dieterich W; Laag E; Bruckner-Tuderman L; Reunala T; Kárpáti S; Zágoni T; Riecken EO; Schuppan D
    J Invest Dermatol; 1999 Jul; 113(1):133-6. PubMed ID: 10417632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findings.
    Beutner EH; Baughman RD; Austin BM; Plunkett RW; Binder WL
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):329-32. PubMed ID: 10901714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients.
    Borroni G; Biagi F; Ciocca O; Vassallo C; Carugno A; Cananzi R; Campanella J; Bianchi PI; Brazzelli V; Corazza GR
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):836-41. PubMed ID: 22672004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue.
    Marietta EV; Camilleri MJ; Castro LA; Krause PK; Pittelkow MR; Murray JA
    J Invest Dermatol; 2008 Feb; 128(2):332-5. PubMed ID: 17762854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
    Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatitis herpetiformis with linear IgA deposition: ultrastructural localization of in vivo bound IgA.
    Yamasaki Y; Hashimoto T; Nishikawa T
    Acta Derm Venereol; 1982; 62(5):401-5. PubMed ID: 6183889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis.
    Koop I; Ilchmann R; Izzi L; Adragna A; Koop H; Barthelmes H
    Am J Gastroenterol; 2000 Aug; 95(8):2009-14. PubMed ID: 10950050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatitis herpetiformis: close to unravelling a disease.
    Kárpáti S
    J Dermatol Sci; 2004 Apr; 34(2):83-90. PubMed ID: 15033190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis.
    Zone JJ; Meyer LJ; Petersen MJ
    Arch Dermatol; 1996 Aug; 132(8):912-8. PubMed ID: 8712841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, histological and immunpathological findings in 32 patients with dermatitis herpetiformis Duhring.
    Rose C; Bröcker EB; Zillikens D
    J Dtsch Dermatol Ges; 2010 Apr; 8(4):265-70, 265-71. PubMed ID: 19878401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatitis herpetiformis: potential for confusion with linear IgA bullous dermatosis on direct immunofluorescence.
    Van L; Browning JC; Krishnan RS; Kenner-Bell BM; Hsu S
    Dermatol Online J; 2008 Jan; 14(1):21. PubMed ID: 18319038
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis.
    Hull CM; Liddle M; Hansen N; Meyer LJ; Schmidt L; Taylor T; Jaskowski TD; Hill HR; Zone JJ
    Br J Dermatol; 2008 Jul; 159(1):120-4. PubMed ID: 18503599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.